FTSE 100 hits two-year high as GSK boosts

Unilever shares dropped 7.0% and were the worst performer on the index. A report said the company was in talks with banks for additional financing to make a potential sweetened offer.

LONDON: London's FTSE ended higher on Monday, aided by healthcare stocks as GlaxoSmithKline jumped after rejecting a 50-billion-pound buyout offer for its consumer arm from Unilever, while energy and mining stocks also provided support.

The blue-chip FTSE 100 index gained 0.9% to record its highest closing in nearly two years, with miner Glencore and energy majors BP and Royal Dutch Shell among the biggest boosts to the index.